1. Home
  2. MAIA vs ORIQ Comparison

MAIA vs ORIQ Comparison

Compare MAIA & ORIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.32

Market Cap

89.7M

Sector

Health Care

ML Signal

HOLD

ORIQ

Origin Investment Corp I Ordinary Shares

N/A

Current Price

$10.20

Market Cap

88.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MAIA
ORIQ
Founded
2018
2024
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.7M
88.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MAIA
ORIQ
Price
$1.32
$10.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
29.1K
Earning Date
03-23-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$10.01
52 Week High
$3.19
$10.24

Technical Indicators

Market Signals
Indicator
MAIA
ORIQ
Relative Strength Index (RSI) 32.95 53.66
Support Level $1.26 $10.01
Resistance Level $1.74 $10.22
Average True Range (ATR) 0.08 0.01
MACD -0.01 -0.00
Stochastic Oscillator 13.85 50.00

Price Performance

Historical Comparison
MAIA
ORIQ

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About ORIQ Origin Investment Corp I Ordinary Shares

Origin Investment Corp I is a blank check company.

Share on Social Networks: